EUVIMEDEUVIMED entdecken
Crossref

Interplay of Vitamin D and Aryl Hydrocarbon Receptors in CD4+ T Cell Fate Determination

Sepideh Maghami, Sara Ranjbar, Navid Nezafat, Atefe Ghamar Talepoor, Mahsa Eshkevar Vakili, Mohammad Hossein Morowvat, Kurosh Kalantar, Afshin Mohammadi Bardbori iD

Journal of Biochemical and Molecular Toxicology · 2025

DOI: 10.1002/jbt.70360 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Sepideh Maghami und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: Receptors, Aryl Hydrocarbon, Cell Differentiation, Receptors, Calcitriol, CD4-Positive T-Lymphocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: This study was supported by the Shiraz University of Medical Sciences grant for the accomplishment of PhD thesis of Sepideh Maghami [Grant number: 24122]..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It seems that vitamin D receptor (VDR) and aryl hydrocarbon receptor (AHR) are important receptors that determine the fate of CD4+ T cell differentiations under various physiological and pathophysiological conditions. Herein, we aim to investigate the potential effects of VDR and AHR ligands on the differentiation of CD4+ T‐cells. Male C57BL/6 mice, were treated with an endogenous ligand of AHR 6‐formylindolo[3,2‐b] carbazole (FICZ), and an AHR antagonist known as CH223191 via intraperitoneal injection, either individually or in combination with Vitamin D3. After 6 days, the mice were killed, and their spleen cells were isolated and analyzed using flow cytometry. Additionally, the ligand binding domain (LBD) of the AHR was modeled using Modeler software, while the molecular docking was performed by AutoDock 1.5.4. Our findings also showed that the AHR antagonist CH223191 increased the prevalence of Th1 cells and altered the Th1/Treg and Th1/Th2 cell ratios. Additionally, the combination of FICZ and Vitamin D3 led to an increase in Th17 and Th2 cells. The molecular docking analysis shows that Vitamin D3 was well accommodated within the binding site of AHR. Molecular docking analysis suggests that vitamin D3 could act as a potential ligand for the AHR. AHR ligands reduce the populations of Th1, Th2, and Treg cells while promoting Th17 differentiation. Furthermore, FICZ alone or in combination with vitamin D3 enhances the differentiation of Th2 and Th17 cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Aryl HydrocarbonCell DifferentiationReceptors, CalcitriolCD4-Positive T-LymphocytesBasic Helix-Loop-Helix ProteinsVitamin DAnimalsMiceMaleMice, Inbred C57BLCarbazolesMolecular Docking Simulation

Stichwörter der Autor:innen

6‐formylindolo[3,2‐b] carbazole (FICZ)CD4+T cell fate determinationTh1/Th2 cell ratiosTh1/Treg cells ratioaryl hydrocarbon receptordockingvitamin D

Substanzen

Receptors, Aryl HydrocarbonReceptors, CalcitriolCarbazolesBasic Helix-Loop-Helix ProteinsVitamin D6-formylindolo(3,2-b)carbazoleAhr protein, mouse

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Computational Vaccine and Drug Design Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Department of Bacteriology & Immunology and the Translational Immunology Research Program (TRIMM), University of Helsinki, Helsinki, Finland.
  • Autoimmune Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

ORCID-Profile: Afshin Mohammadi Bardbori

Förderung

  • This study was supported by the Shiraz University of Medical Sciences grant for the accomplishment of PhD thesis of Sepideh Maghami [Grant number: 24122].

Zitieren

APA

Maghami, S., Ranjbar, S., Nezafat, N., Ghamar Talepoor, A., Eshkevar Vakili, M., Morowvat, M. H., Kalantar, K., & Mohammadi Bardbori, A. (2025). Interplay of Vitamin D and Aryl Hydrocarbon Receptors in CD4+ T Cell Fate Determination. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70360

Vancouver

Maghami S, Ranjbar S, Nezafat N, Ghamar Talepoor A, Eshkevar Vakili M, Morowvat MH, et al. Interplay of Vitamin D and Aryl Hydrocarbon Receptors in CD4+ T Cell Fate Determination. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70360

BibTeX
@article{Maghami2025,
  author = {Maghami, Sepideh and Ranjbar, Sara and Nezafat, Navid and Ghamar Talepoor, Atefe and Eshkevar Vakili, Mahsa and Morowvat, Mohammad Hossein and Kalantar, Kurosh and Mohammadi Bardbori, Afshin},
  title = {Interplay of Vitamin D and Aryl Hydrocarbon Receptors in CD4+ T Cell Fate Determination},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2025},
  doi = {10.1002/jbt.70360}
}
Kostenlos starten →